Ear vagus nerve stimulation to improve motivation and insulin sensitivity
Official title: Acute Effects of Non-invasive Vagus Nerve Stimulation on Motivation and Its Dependency on Insulin Sensitivity in Patients With Depression and Controls
Run by University of Bonn · NCT07198100 · Data updated 2026-11-12
This trial will test whether short sessions of non-invasive ear vagus nerve stimulation can improve motivation and mood in adults with major depression and whether a person’s insulin sensitivity changes those effects.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of Bonn Academic / other |
| Locations | 1 site (Bonn) |
| Status | Recruiting |
| Started | October 10, 2025 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | December 24, 2025 |
| Trial ID | NCT07198100 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults aged 18–60 with BMI 18.5–40 kg/m² who either have a DSM-5 diagnosis of major depressive disorder or are matched healthy controls, and who can undergo MRI, oGTT, blood draws, and wear a glucose sensor.
✕Probably not a fit
People with contraindications such as MRI-incompatible implants, ear conditions that prevent taVNS, type 1 diabetes, recent severe psychiatric disorders (eg, bipolar disorder, schizophrenia), or major cardiac/neurological conditions are unlikely to benefit or cannot participate.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study will enroll 60 adults with major depressive disorder and 60 matched control participants across a wide BMI and insulin-sensitivity range, including people with type 2 diabetes. Participants complete an intake with clinical interviews, fasting blood work, and a battery of reward and effort tasks, then wear a continuous glucose sensor and complete ecological momentary assessments for two weeks. Insulin sensitivity is measured with an oral glucose tolerance test while participants receive randomized acute transcutaneous auricular vagus nerve stimulation (tVNS) versus sham on separate days, and two randomized neuroimaging sessions use concurrent fMRI and electrogastrography to measure brain and stomach responses. The design is single-blind (participants), includes a minimum 2-day washout between stimulation conditions, and collects additional metabolic, questionnaire, and optional genetic biobank data to characterize participants.
Why it matters
Potential benefit: If successful, this could offer a non-invasive way to boost motivation and mood, particularly for patients whose metabolic state (insulin resistance) contributes to anhedonia.
How similar studies have gone: Preclinical work and some clinical tVNS studies have shown promising effects on mood and motivation, but combining acute tVNS with insulin-sensitivity testing and stomach–brain coupling measurements is a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Participants with depression (DSM-5 diagnosis) or participants without depression (no DSM-5 diagnosis, lifetime) * BMI between 18.5 and 40 kg/m² * Age between 18 and 60 years * Legally valid informed consent Exclusion criteria: The following diagnoses in medical history: * Brain injury * Schizophrenia * Bipolar disorder * Severe substance use disorder * Coronary heart disease * Stroke * Epilepsy * Chronic inflammatory diseases (e.g., rheumatoid arthritis, Crohn's disease, etc.) * Type I diabetes The following diagnoses within 12 months prior to the experiment: * Obsessive-compulsive disorder * Somatic symptom disorder * Eating disorder The following diagnoses in medical history for control participants: * Depression * Anxiety disorders (except specific phobias) Generally: * Contraindications for MRI (e.g., metal implants, claustrophobia) or taVNS (e.g., piercings, sore or diseased skin on the outer right ear) * Pregnant and breastfeeding women will not be included * Unclear capacity to consent * Stomach surgeries affecting body weight (e.g., bypass surgeries)
Where it's running
-
Section of Medical Psychology, Department of Psychiatry & Psychotherapy, Faculty of Medicine, University of Bonn
Bonn, Germany Recruiting
Study contacts
- Principal investigator: Nils B Kroemer, Prof. Dr. — Section of Medical Psychology, Department of Psychiatry & Psychotherapy, Faculty of Medicine, University of Bonn, 53127 Bonn, Germany
- Study coordinator: Nils B Kroemer, Prof. Dr.
- Email: nkroemer@uni-bonn.de
- Phone: +49 228 287 11151
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures
This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.
-
Temporally Interfering Electrical Stimulation for Major Depressive Disorder
This study tests whether noninvasive temporally interfering electrical stimulation can help people with major depressive disorder.
-
Affective Cognitive Training for mood disorders and their close relatives
A six-week program combining virtual reality and computer exercises tests whether affective cognitive training helps people with mood disorders and their unaffected first-degree relatives.
-
ALKS 7290 added to antidepressants for adults with major depression
This study tests whether ALKS 7290, taken with current antidepressants, helps adults with major depressive disorder.
-
French Minds: a French, Multimodal Cohort Study of Severe Psychiatric Disorders and Healthy Controls
This study tests whether people with mood, psychotic, or autism disorders can be grouped into more similar subtypes based on social withdrawal and anhedonia, across ages 15 to 60.
-
EEG-Guided TMS for Adults With Depression
This study tests whether delivering intermittent theta burst stimulation (iTBS) timed to brain waves using EEG can improve treatment for adults with major depressive disorder who have not responded to usual antidepressants.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.